Menopause: The Workplace Blind Spot Costing Billions | Karen Bishop, MS - Senior Director of HR Rewards, Astellas Pharma US

Episode notes

Send us Fan Mail We tend to think of menopause as a personal health issue - but in the workplace it quietly shows up as one of the largest unmodeled productivity shifts in the modern economy. Recent data from the Korn Ferry Institute, in collaboration with Vira Health, suggests nearly half of women report that perimenopause or menopause symptoms impact their work performance. And research cited by the Mayo Clinic estimates menopause-related productivity loss in the U.S. alone at roughly $1.8 billion annually. So the question becomes: what happens when a normal biological transition starts to meaningfully affect workforce participation, retention, and productivity? Karen Bishop, MS is Senior Director of HR Rewards at Astellas Pharma US ( ), where she leads global benefits, compensation strategy, and employee well-being programs. Across more than two decades in HR leadership roles at organizations including MilliporeSigma, Shire (now Takeda), Cabot Corporation, and Putnam Investments, Karen has built deep expertise in total rewards strategy, healthcare benefits design, retirement systems, and organizational change.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

• Modern Work: Monitored, Misled, and Laid OffYour Work Friends · on Future of Work80 / 100
• Women still aren't taken seriously in construction with Kimberley ChutSpace by Stansons · on Future of Work68 / 100
• 502 - The Eras Tour: Part 3 (The hybrid period)The Mindtools L&D Podcast · on Workplace wellbeing67 / 100
• AA259 - The Memo IS the Strategy (And How You MIGHT Be Running It Too)Arguing Agile · on corporate strategy58 / 100
• The Week in Jobs: CEO Confidence Declines, Top AI Bosses Are Split, And Fraud Is On The RiseCornering The Job Market · on Future of Work57 / 100
• Layoffs, AI, and Respect: A Conversation with Shashank BhushanAsk Ashley · on HR leadership55 / 100

• Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100
• Reversing Cellular Age: The Scientist Who Helped Create iPS Cells Reveals What’s Next - Dr. Koji Tanabe, Ph.D. - Founder and CEO, I Peace Inc.
• Inside the Global Biotech Ecosystem - Where Innovation Goes Next | Sara Jane Demy - Founder and CEO, Demy-Colton
• The End of High Cholesterol? The First Oral PCSK9 Drug Could Change Heart Medicine Forever - Dr. Norman Lepor, MD - Founder and Director, National Heart Institute
• The Hidden Heart Risk: Amgen’s Dr. Paul Burton on the Future of Preventing Heart Attacks - Dr. Paul Burton, M.D., Ph.D., F.A.C.C., M.R.C.S., F.R.C.P. - Senior Vice President and Chief Medical Officer - Amgen